Medtronic wins US FDA approval for Onyx 12 liquid embolic system for subdural hematoma treatment
MDT•FDA also shortens prep time for Onyx 18 and Onyx 34
The FDA also cleared a 1-minute prep shake time for Onyx 18 and Onyx 34, down from 20 minutes.
FDA clears Onyx 12 for subdural hematoma surgery support
Medtronic won US FDA clearance for its Onyx 12 Liquid Embolic System to support surgery for symptomatic subacute or chronic subdural hematoma.
The product targets middle meningeal artery embolization; initial US rollout is set to begin in coming days.
